<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02583906</url>
  </required_header>
  <id_info>
    <org_study_id>S55742</org_study_id>
    <nct_id>NCT02583906</nct_id>
  </id_info>
  <brief_title>Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment</brief_title>
  <official_title>Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the effect of CPAP (continuous positive airway pressure ) treatment in PAH
      (pulmonary arterial hypertension) and CTEPH (chronic thromboembolic pulmonary hypertension)
      patients suffering from sleep disordered breathing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary endpoint of the study is to evaluate the effect of CPAP therapy on pulmonary
      vascular resistance in PAH and CTEPH patients suffering from sleep disordered breathing.

      The secondary endpoints are the effect of CPAP on right atrium and right ventricle diameter
      and ejection fraction measured by echocardiography, 6 minutes walk distance, NYHA class, QOL,
      endothelial function, sympathetic activity and prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in PVR (pulmonary vascular resistance)</measure>
    <time_frame>change in PVR from inclusion at 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Sleep-Disordered Breathing</condition>
  <condition>Pulmonary Arterial Hypertension</condition>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>cpap treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients randomized to the 'no cpap' arm will not be treated by CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no cpap</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients randomized to the 'cpap' arm will be treated by CPAP</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Treatment with CPAP for six months in the CPAP arm.</description>
    <arm_group_label>cpap treatment</arm_group_label>
    <other_name>CONTINUOUS POSITIVE AIRWAY PRESSURE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  minimum 18 years old

          -  diagnosed with PAH or non-operable CTEPH or operated CTEPH with peristent pulmonary
             hypertension

          -  diagnosis of PAH based on cardiac catherisation

          -  diagnosis of CTEPH confirmed by contrast-enhanced spiral chest CT, pulmonary
             angiography and V/Q scintigraphy

          -  recent diagnosis of sleep disordered breathing (polysomnography realized within 3
             months before inclusion showing AHI above 15) stable clinical condition for at least 3
             months before inclusion as defined by NYHA and a walking distance difference within
             10% of the previous 3 months and no change in medical therapy during this 3 months

        Exclusion Criteria:

          -  congenital heart disease

          -  moderate and severe restrictive or obstructive pulmonary disease with a TLC and a
             FEV1&lt;60% of the predicted value

          -  BMI 35kg/m2 or more

          -  patients already treated with CPAP

          -  patients with severe sleepiness (epworth sleepiness scale from 18 to 24/24)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catharina Belge, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catharina Belge, MDPhD</last_name>
    <phone>+3216346800</phone>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catharina Belge</last_name>
      <phone>+3216346800</phone>
    </contact>
    <investigator>
      <last_name>Catharina Belge, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2015</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Prof Dr Catharina belge</investigator_full_name>
    <investigator_title>Prof Dr Catharina Belge</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

